EUVIMEDEUVIMED entdecken
Korrektur

Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”

Human Gene Therapy · 14.06.2026

DOI: 10.1177/10430342261456423 ↗

Kurz gefasst

Korrektur in der Zeitschrift Human Gene Therapy, online erschienen am 14.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”. Human Gene Therapy. https://doi.org/10.1177/10430342261456423

Vancouver

Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”. Human Gene Therapy. 2026. doi:10.1177/10430342261456423

BibTeX
@article{euvimed2026,
  title = {Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”},
  journal = {Human Gene Therapy},
  year = {2026},
  doi = {10.1177/10430342261456423}
}
Kostenlos starten →